Desert Dialysis Center South Tucson (DCI) is a medicare approved dialysis facility center in Tucson, Arizona and it has 25 dialysis stations. It is located in Pima county at 1011 E Pennsylvania St, Tucson, AZ, 85719. You can reach out to the office of Desert Dialysis Center South Tucson (DCI) at (520) 806-0007. This dialysis clinic is managed and/or owned by Dialysis Clinic, Inc.. Desert Dialysis Center South Tucson (DCI) has the following ownership type - Non-Profit. It was first certified by medicare in September, 1997. The medicare id for this facility is 032565 and it accepts patients under medicare ESRD program.
| Name | Desert Dialysis Center South Tucson (DCI) |
|---|---|
| Location | 1011 E Pennsylvania St, Tucson, Arizona |
| No. of Dialysis Stations | 25 |
| Medicare ID | 032565 |
| Managed By | Dialysis Clinic, Inc. |
| Ownership Type | Non-Profit |
| Late Shifts | Yes |
| 1011 E Pennsylvania St, Tucson, Arizona, 85719 | |
| (520) 806-0007 | |
News Archive
The Coca-Cola Company and the Global Fund to Fight AIDS, Tuberculosis and Malaria have announced the expansion of a pilot project, called "Project Last Mile," that uses Coca Cola's "'expansive global distribution system and core business expertise' to help deliver critical medicines to remote parts of the world, beginning in rural Africa," Pharma Times reports.
Should researchers inform research participants, if they discover genetic disease risks in the participants? Yes, many would say, if the information is helpful to the participants.
Alere Inc., a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, announced today that it has made additional open market purchases of 2,091,764 shares of Axis-Shield stock, bringing its total current ownership position to 3,204,995 shares, or approximately 6.4%, of Axis-Shield's issued and outstanding ordinary share capital.
In a new University of California, Irvine-led study, researchers have discovered how regulatory T cells (Treg) are instrumental in limiting the damage caused to the spinal cord in diseases like multiple sclerosis (MS).
› Verified 6 days ago
| NPI Number | 1871526251 |
| Doing Business As | Dialysis Clinic Inc. |
| Address | 1011 E Pennsylvania St Tucson, Arizona, 85714 |
| Phone Number | (520) 806-0071 |
News Archive
The Coca-Cola Company and the Global Fund to Fight AIDS, Tuberculosis and Malaria have announced the expansion of a pilot project, called "Project Last Mile," that uses Coca Cola's "'expansive global distribution system and core business expertise' to help deliver critical medicines to remote parts of the world, beginning in rural Africa," Pharma Times reports.
Should researchers inform research participants, if they discover genetic disease risks in the participants? Yes, many would say, if the information is helpful to the participants.
Alere Inc., a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, announced today that it has made additional open market purchases of 2,091,764 shares of Axis-Shield stock, bringing its total current ownership position to 3,204,995 shares, or approximately 6.4%, of Axis-Shield's issued and outstanding ordinary share capital.
In a new University of California, Irvine-led study, researchers have discovered how regulatory T cells (Treg) are instrumental in limiting the damage caused to the spinal cord in diseases like multiple sclerosis (MS).
› Verified 6 days ago
| Dialysis patients with Hemoglobin data | 29 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 3 |
News Archive
The Coca-Cola Company and the Global Fund to Fight AIDS, Tuberculosis and Malaria have announced the expansion of a pilot project, called "Project Last Mile," that uses Coca Cola's "'expansive global distribution system and core business expertise' to help deliver critical medicines to remote parts of the world, beginning in rural Africa," Pharma Times reports.
Should researchers inform research participants, if they discover genetic disease risks in the participants? Yes, many would say, if the information is helpful to the participants.
Alere Inc., a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, announced today that it has made additional open market purchases of 2,091,764 shares of Axis-Shield stock, bringing its total current ownership position to 3,204,995 shares, or approximately 6.4%, of Axis-Shield's issued and outstanding ordinary share capital.
In a new University of California, Irvine-led study, researchers have discovered how regulatory T cells (Treg) are instrumental in limiting the damage caused to the spinal cord in diseases like multiple sclerosis (MS).
› Verified 6 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 71 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 633 |
| Percentage of adult patients getting regular hemodialysis at the center | 94 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
The Coca-Cola Company and the Global Fund to Fight AIDS, Tuberculosis and Malaria have announced the expansion of a pilot project, called "Project Last Mile," that uses Coca Cola's "'expansive global distribution system and core business expertise' to help deliver critical medicines to remote parts of the world, beginning in rural Africa," Pharma Times reports.
Should researchers inform research participants, if they discover genetic disease risks in the participants? Yes, many would say, if the information is helpful to the participants.
Alere Inc., a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, announced today that it has made additional open market purchases of 2,091,764 shares of Axis-Shield stock, bringing its total current ownership position to 3,204,995 shares, or approximately 6.4%, of Axis-Shield's issued and outstanding ordinary share capital.
In a new University of California, Irvine-led study, researchers have discovered how regulatory T cells (Treg) are instrumental in limiting the damage caused to the spinal cord in diseases like multiple sclerosis (MS).
› Verified 6 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Desert Dialysis Center South Tucson (DCI) with elevated calcium levels.
| Patients with hypercalcemia | 77 |
| Hypercalcemia patient months | 703 |
| Hypercalcemia patients with serumcalcium greater than 10.2 mg | 1 |
| Patients with Serumphosphor | 80 |
| Patients with Serumphosphor less than 3.5 mg/dL | 9 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 19 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 22 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 29 |
| Patients with Serumphosphor greater than 7 mg/dL | 22 |
News Archive
The Coca-Cola Company and the Global Fund to Fight AIDS, Tuberculosis and Malaria have announced the expansion of a pilot project, called "Project Last Mile," that uses Coca Cola's "'expansive global distribution system and core business expertise' to help deliver critical medicines to remote parts of the world, beginning in rural Africa," Pharma Times reports.
Should researchers inform research participants, if they discover genetic disease risks in the participants? Yes, many would say, if the information is helpful to the participants.
Alere Inc., a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, announced today that it has made additional open market purchases of 2,091,764 shares of Axis-Shield stock, bringing its total current ownership position to 3,204,995 shares, or approximately 6.4%, of Axis-Shield's issued and outstanding ordinary share capital.
In a new University of California, Irvine-led study, researchers have discovered how regulatory T cells (Treg) are instrumental in limiting the damage caused to the spinal cord in diseases like multiple sclerosis (MS).
› Verified 6 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 48 |
| Patient months included in arterial venous fistula and catheter summaries | 365 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 90 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 5 |
News Archive
The Coca-Cola Company and the Global Fund to Fight AIDS, Tuberculosis and Malaria have announced the expansion of a pilot project, called "Project Last Mile," that uses Coca Cola's "'expansive global distribution system and core business expertise' to help deliver critical medicines to remote parts of the world, beginning in rural Africa," Pharma Times reports.
Should researchers inform research participants, if they discover genetic disease risks in the participants? Yes, many would say, if the information is helpful to the participants.
Alere Inc., a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, announced today that it has made additional open market purchases of 2,091,764 shares of Axis-Shield stock, bringing its total current ownership position to 3,204,995 shares, or approximately 6.4%, of Axis-Shield's issued and outstanding ordinary share capital.
In a new University of California, Irvine-led study, researchers have discovered how regulatory T cells (Treg) are instrumental in limiting the damage caused to the spinal cord in diseases like multiple sclerosis (MS).
› Verified 6 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 57 |
| Hospitalization Rate in facility | 154.7 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 287.1 |
| Hospitalization Rate: Lower Confidence Limit | 87 |
News Archive
The Coca-Cola Company and the Global Fund to Fight AIDS, Tuberculosis and Malaria have announced the expansion of a pilot project, called "Project Last Mile," that uses Coca Cola's "'expansive global distribution system and core business expertise' to help deliver critical medicines to remote parts of the world, beginning in rural Africa," Pharma Times reports.
Should researchers inform research participants, if they discover genetic disease risks in the participants? Yes, many would say, if the information is helpful to the participants.
Alere Inc., a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, announced today that it has made additional open market purchases of 2,091,764 shares of Axis-Shield stock, bringing its total current ownership position to 3,204,995 shares, or approximately 6.4%, of Axis-Shield's issued and outstanding ordinary share capital.
In a new University of California, Irvine-led study, researchers have discovered how regulatory T cells (Treg) are instrumental in limiting the damage caused to the spinal cord in diseases like multiple sclerosis (MS).
› Verified 6 days ago
The rate of readmission show you whether patients who were being treated regularly at Desert Dialysis Center South Tucson (DCI) were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 15.3 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 27.7 |
| Readmission Rate: Lower Confidence Limit | 7 |
News Archive
The Coca-Cola Company and the Global Fund to Fight AIDS, Tuberculosis and Malaria have announced the expansion of a pilot project, called "Project Last Mile," that uses Coca Cola's "'expansive global distribution system and core business expertise' to help deliver critical medicines to remote parts of the world, beginning in rural Africa," Pharma Times reports.
Should researchers inform research participants, if they discover genetic disease risks in the participants? Yes, many would say, if the information is helpful to the participants.
Alere Inc., a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, announced today that it has made additional open market purchases of 2,091,764 shares of Axis-Shield stock, bringing its total current ownership position to 3,204,995 shares, or approximately 6.4%, of Axis-Shield's issued and outstanding ordinary share capital.
In a new University of California, Irvine-led study, researchers have discovered how regulatory T cells (Treg) are instrumental in limiting the damage caused to the spinal cord in diseases like multiple sclerosis (MS).
› Verified 6 days ago